NEW YORK, July 3, 2018 /PRNewswire/ --
FinancialBuzz.com News Commentary
According to data compiled by Oristep Consulting, the global medical cannabis market was worth USD
12.67 Billion in 2016 and will reach USD 33.41 Billion by 2022 at a CAGR of 17.53% over the
forecast period. The two main cannabinoids from the cannabis plant are THC and CBD, and both are commonly used as medication for
increasing appetite, reducing nausea, decreasing pain, inflammation (swelling and redness), as well as dealing with
muscle-control problems. The report also specifies that North America leads the market, having
held nearly half of the market share in 2016. WeedMD Inc. (OTC: WDDMF), Organigram Holdings Inc. (OTC: OGRMF), Aphria Inc. (OTC:
APHQF), Cannabis Sativa Inc. (OTC: CBDS), General Cannabis Corporation (OTC: CANN)
As a result of the strong sales figures across the industry, investments in cannabis are piling up. A report by Business
Insider indicates that, "Venture-capital investors from around the world spent USD 355 Million on
100 marijuana-industry deals in 2017, and 2018 is on pace to break last year's record. By the end of February, there were 19
venture-backed deals in the industry worth USD 176 Million alone, and that doesn't factor in the
money investors have poured into hedge funds set up to take advantage of the budding industry."
WeedMD Inc. (OTC: WDDMF) is also listed on the Toronto Stock Exchange Venture under (TSX-V: WMD). Earlier last week,
the Company announced, "that the first batch of cannabis plants have been transplanted to its modern greenhouse located in
Strathroy, Ontario and are scheduled for harvest by September
2018.
'Our initial crop of plants successfully entered our recently-licensed Strathroy greenhouse
last week and our first 10,000 sq. ft. grow room is now fully operational,' said Keith Merker,
Chief Financial Officer of WeedMD. 'With this hybrid, large-scale, modern greenhouse, we will be able to produce quality cannabis
with maximum efficiency. This facility will be the prominent source of supply for our medical cannabis patients and for future
adult-use consumers across Canada and emerging international markets. I want to acknowledge and
thank our incredibly dedicated, passionate and experienced best-in-class cultivation team.'
Strathroy Greenhouse Facility Updates:
- Secured Health Canada cultivation license for the first four grow rooms at its Strathroy
facility on June 11th, 2018.
- Initial harvest expected by September 2018.
- Phase I, 220,000 sq. ft. retrofit is scheduled for completion this fall, with plans to progressively bring a total of 20
grow rooms online expanding annual production to more than 21,000 kg.
- Phase II fully-funded expansion is underway with an incremental 175,000 sq. ft. conversion, representing additional
potential annual yield of more than 12,000 kg, bringing the total to more than 33,000 kg by this year-end.
- Phase III involves retrofitting the remaining 215,000 sq. ft., bringing the total square footage to 610,000 sq. ft, and
total annual production capacity to more than 50,000 kg.
For more information, access our investor presentation here and corporate video here."
Organigram Holdings Inc. (OTCQB: OGRMF) is a leading licensed producer of medical marijuana based in Moncton, New Brunswick. Recently, the Company announced that it has been approved as a supplier of cannabis
for the province of Manitoba. The agreement with MBLL represents another milestone in the
Company's strategic plan to work with regulators and distributors across the country. Organigram has signed two previous
memorandums of understanding including an MOU with the Government of New Brunswick (GNB), signed
in 2017 to supply a minimum of 5-Million grams of cannabis a year worth an estimated retail value of between USD 40-Million to USD 60-Million per year. In 2018, the Company also signed an
MOU with the Prince Edward Island Liquor Control Commission for the distribution of cannabis to the province's adult recreational
market. That agreement is estimated to have a retail value of between USD 8-Million to USD 12-Million per year.
Aphria Inc. (OTCQB: APHQF) is a leading global cannabis company driven by an unrelenting commitment to the people,
product quality and innovation. Recently, the Company announced that it has signed a Supply Agreement with the Manitoba Liquor
and Lotteries Corporation to provide a portfolio of high-quality, branded cannabis and cannabis derivative products for sale in
Manitoba's adult-use market. Under the terms of the Agreement, the Company will supply up to 2.7
Million grams of cannabis and cannabis derivative products in the first year of the agreement, including both Ontario and BC dried flower, pre-rolls and cannabis oils. The wide range of products will be available for
sale at licensed retailers across the province. It is anticipated that additional products currently being developed by Aphria,
such as vapes and edibles, will also be made available in Manitoba when authorized for sale
under the Cannabis Act.
Cannabis Sativa Inc. (OTCQB: CBDS) is engaged in the licensing of cannabis related intellectual property, marketing and
branding for cannabis-based products and services, operation of cannabis related technology services, and ancillary business
activities. In April, the Company announced that PrestoDoctor®, the leading online medical marijuana recommendation service, will
be expanding to Pennsylvania on April 20th, 2018. More than 3,800
people have signed up in the medical marijuana patient registry's first week, signaling strong statewide interest in the program
that will give those with one of 17 specific diagnoses access to cannabis beginning next year. PrestoDoctor® is addressing the
lack of physicians with its #1 ranked telemedicine platform, which streamlines much of the process. In addition to enjoying an
easier process in pursuing a medical marijuana card, patients using PrestoDoctor® will also receive a customized treatment plan
created by a PrestoDoctor® physician.
General Cannabis Corporation (OTCQX: CANN) is the comprehensive resource for the highest quality service providers
available to the regulated Cannabis Industry. On May 14, 2018, the Company announced financial
results for the quarter ended March 31, 2018. Robert Frichtel, Chief
Executive Officer of General Cannabis, said, "General Cannabis announced first quarter financial results today. For the first
quarter of 2018, we reported revenues of USD 942,482, a 31% increase over 2017 first quarter
revenues of USD 719,105. Our existing operations in Colorado
continue to prosper with Security, Marketing and Operations segments each showing strong year-over-year revenue growth. The
team and infrastructure we have built allows us to scale with the continued expansion within cannabis industry."
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For WeedMD Inc. financial news dissemination and PR services, FinancialBuzz.com has
been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or
negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are
commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of
the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR
advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post
information about any companies the information contained herein is not intended to be used as the basis for investment decisions
and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or
solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or
losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or
presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their
investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and
financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by
the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com
constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment
strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is
solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives,
other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and
legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless
of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be
reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please
visit: http://www.financialbuzz.com .
For further information:
Media Contact: info@financialbuzz.com , +1-877-601-1879
SOURCE FinancialBuzz.com